Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals by Beth Mole from Ars Technica - All content on 2024-10-15 21:53 (#6RG9R) FDA is reviewing its decision to remove tirzepatide drugs from the shortage list.
